The platform, dubbed Molecular Targets Platform, will streamline and catalyze drug development by using six major data sources pertaining to pediatric cancer targets, genes and pathways, according to an Aug. 4 press release.
The platform is publicly available for research into childhood cancer therapies.
Children’s Hospital of Philadelphia aims for the platform to be utilized by investigators in academia, industry, the FDA and patient advocates.
The project is funded by research and development firm Leidos Biomed, which will provide more than $3 million a year to the health system to develop and maintain the new platform.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
